WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.


L03 IMMUNOSTIMULANTS

Immunosuppressants, see L04A.


L03A IMMUNOSTIMULANTS

Levamisole, which also affects the immune response, is classified in P02CE.


L03AA Colony stimulating factors

The DDDs for pegfilgrastim (L03AA13) and lipegfilgrastim (L03AA14) are based on the declared amount of filgrastim and on the use of one single dose per cycle of chemotherapy. The DDDs for the other G-CSFs are based on daily dosing for six subsequent days.


    ATC code  Name  DDD  U Adm.R Note
    L03AA13 pegfilgrastim 0.3 mg 

List of abbreviations

Last updated: 2024-01-26